A bcl-xS Adenovirus Selectively Induces Apoptosis in Transformed Cells Compared to Normal Mammary Cells

Krajewski, 1994, Immunohistochemical analysis of in vivo patterns of Bcl-x expression, Cancer Res, 54, 5501 Olufunmilayo, 1997, Overexpression of Bcl-X in primary breast cancer is associated with high tumor grade and metastases, The Cancer Journal from Scientific American, 3, 230 Boise, 1993, bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death, Cell, 74, 597, 10.1016/0092-8674(93)90508-N Sumantran, 1995, Overexpression of Bcl-xS sensitizes MCF-7 cells to chemotherapy induced apoptosis, Cancer Res, 55, 2507 Ealovega, 1996, bcl-xS gene therapy induces apoptosis of human mammary tumors in Nude mice, Cancer Res, 56, 1965 Evan, 1992, Induction of apoptosis in fibroblasts by c-myc protein, Cell, 69, 119, 10.1016/0092-8674(92)90123-T Thompson, 1998, The many roles of c-myc in apoptosis, Adv Pharmacol, 41, 575 Berns, 1996, Evaluation of markers for metastasis and oncogene amplification as prognostic factors in 496 primary breast cancer patients (Meetings Abstract), Breast Cancer Res Treat, 37, 34 Slamon, 1987, Human breast cancer: correlation of relapse and survival with amplification of the Her-2/neu oncogene, Science, 235, 177, 10.1126/science.3798106 Berger, 1988, Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading, Cancer Res, 48, 1238 Amundadottir, 1996, Cooperation of TGF-α and c-myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis, Oncogene, 13, 757 Danielson, 1989, Clonal populations of the mouse mammary cell line Comma -iD which retain ability of morphogenesis in vivo, In Vitro Cell Dev Biol, 25, 535, 10.1007/BF02623566 Band, 1990, Tumor progression in four mammary epithelial cell lines derived from the same patient, Cancer Res, 50, 7351 Harris, 1998, Novel mechanisms of E2F induction by BK virus large T antigen: requirement of both pRb binding and J domains, Mol Cell Biol, 18, 1746, 10.1128/MCB.18.3.1746 Ignatoski, 1999, erbB2 overexpression in human mammary epithelial cells confers growth factor Independence, Endocrinology, 140, 3615, 10.1210/endo.140.8.6939 Clarke, 1995, A recombinant bcl-xS adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells, Proc Natl Acad Sci USA, 92, 11024, 10.1073/pnas.92.24.11024 Strafford-Pericaudet, 1992, Widespread long-term gene transfer to mouse skeletal muscles and heart, J Clin Invest, 90, 626, 10.1172/JCI115902 Arakawa, 1991, Chemiluminescent assay of various enzymes using indoxyl derivatives as substrate and its applications to enzyme immunoassay and DNA probe assay, Anal Biochem, 199, 238, 10.1016/0003-2697(91)90096-C Kao, 1995, Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection, Carcinogenesis, 16, 531, 10.1093/carcin/16.3.531 Ignatoski, 1999, Constitutive activation of pp125 fak in newly isolated human breast cancer cell lines, Breast Cancer Res Treat, 54, 173, 10.1023/A:1006135331912 Serra, 1994, TGF-,/3 1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures, Development, 120, 2153, 10.1242/dev.120.8.2153 Ignatoski KMW, Maehama T, Markwart SM, Dixon JE, Livant DL, and Ethier SP (in press). erbB2 overexpression confers PI-3′ kinase dependent invasion capacity on Human Mammary Epithelial cells. BrJ Cancer. In press. Reed, 1997, Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer, 1998. Adv Pharmacol, 41, 501 Evan, 1995, Apoptosis and the cell cycle, Curr Opin Cell Blol, 7, 825, 10.1016/0955-0674(95)80066-2 Pegram, 1997, The effect of Her-2/neu overexpression on the chemotherapeutic drug sensitivity in human breast and ovarian cancer cells, Oncogene, 15, 537, 10.1038/sj.onc.1201222